DOCSLIB.ORG

Media Kit 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Media Kit 2018 MEDIA KIT 2018 New YORK CITY October 25, 2018 / 4 PRIX GALIEN USA FOUNDING COMMITTEE / 5 2018 AWARDS COMMITTEE / 6-7 GALIEN FORUM Overview & Background “They participated in the Forum” / 8-9 TESTIMONIALS FROM AROUND THE GLOBE / 10 HALL OF FAME - HISTORY OF THE PRIZE AND MEDAL / 11 PRIX GALIEN USA / 12 THE PRO BONO HUMANUM AWARD / 13 WHO WAS GALEN / 14 PRIX GALIEN MEDSTART UP / 15 PRIX GALIEN USA WINNERS Pre-event & On-site Resources for Journalists For more information and Galien Foundation events are conducted fully on the record, and we welcome register for a press pass and invite members of the media to participate as engaged stakeholders via please contact: onsite discussion, as well as via social media, and to report on proceedings and outcomes. Finn Partners Holmes Report & PR News We certainly appreciate coverage of our events, but our priority is to help you Midsize Agency of the Year explore and uncover today’s key issues and connect with the people and diverse organizations we bring together that make the world a healthier place. Contact: Giana Gregga To help facilitate your engagement with our speakers and stakeholders, T +1 312 329 3910 we are delighted to work with you in the lead-up to our 2018 Forum and M +1 708 703 2210 Ceremony on: [email protected] Arranging interviews with key speakers Helpful links and stakeholders www.galienfoundation.org Prix Galien USA Reserving private spaces for on-site interviews Forum (latest programs, participants, Sharing our latest programs and speaker lists registration, and reports) Pro Bono Humanum Award Providing hi-resolutions imagery (including photos Med StartUp Award of people, spaces, logos, etc.) Prix Galien Around the Globe Prix Galien Hall of Fame 2 innovation to improve the human condition Mission Sue Desmond-Hellmann, Ethiopia Clinic site visit The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the and politics. The outcome we seek is guided by the development of innovative drugs and synthesis principle that underpins the conduct of other treatments. science itself: successful innovation where financing, physical assets, knowledge and skills are combined from many sources to move new ideas quickly “from The Prix Galien was created in 1970 in the bench to the bedside,” on behalf of patients everywhere. honor of Galen, the father of medical science and modern pharmacology. A truly global program present in 14 countries* Our program includes a review of contributions from Worldwide the Prix Galien is regarded a new generation of innovators representing diverse as the equivalent of the Nobel Prize in sectors in health. Our theme: better cross-cultural contacts, harmonized regulation, internal business biopharmaceutical research. process improvements, new information technologies and effective public-private partnerships can remove barriers to the commercialization of good medicines and The Prix Galien is more than an award: it is a expand access to these benefits to all who need them. movement with a mandate to foster, recognize and reward excellence in scientific innovation to improve the state of human health. Building on an unrivaled 2018 network of Top biomedical scientists including Nobel Through our partnership with the Élie Wiesel Foundation Laureates in medicine, the Prix Galien manages an for Humanity and our first initiative in Africa, 2018 will independent, cross-functional and geographically represent a new and exciting stage in the evolution of diverse program of events and sponsorships to the Prix Galien as the pre-eminent “force populaire” brand “the best of the best” in new medicines and behind the global scientific enterprise. With the support diagnostics. of our sponsoring organizations, our efforts will extend to all who see medical innovation not only as an Our scope is global, and our commitment to industrial policy asset but as a source of social progress progress in medicine is both measurable and concrete. – where private enterprise and public engagement Our members express this through the establishment combine to deliver a greater public good. of productive relationships to build lasting bridges between the commercial research enterprise and local We invite all communities with a commitment to the communities engaged in public policy, science, finance, conduct and promotion of life sciences innovation to academic research and the media. contribute to this important work. In addition to recognizing advances in promising therapies, the Prix Galien’s annual Pro Bono Humanum * Belgium, Canada, China, France, Germany, Greece, Italy, Award for humanitarian achievements brings a unique Netherlands, Poland, Russia, Spain, Switzerland, United focus to the intersection between science, business Kingdom and the United States. 3 Elie WIESEL In Memoriam Honorary Founding President The Galien Foundation Peace Nobel Laureate Boston University Committee 2007-2011 Michael S. BROWN, MD Barry S. COLLER, MD Walter GILBERT, PhD Joseph GOLDSTEIN, MD Nobel Laureate Vice President for Nobel Laureate Nobel Laureate Professor of Molecular Medical Affairs Professor Emeritus Professor of Molecular Genetics and Internal Medicine and Physician-in-Chief, Harvard University Genetics and Internal Medicine UT Southwestern Rockefeller University UT, Southwestern Medical Center at Dallas Medical Center at Dallas Paul GREENGARD, PhD Eric R. KANDEL, MD Joshua LEDERBERG, M.D. Ph.D. Richard A. LERNER, M.D. Nobel Laureate Nobel Laureate Nobel Laureate Professor of Immunochemistry, Professor of Molecular Professor of physiology Professor Emeritus, Chair in Chemistry and Cellular Neuroscience and Cellular Biophysics Laboratory of Molecular Genetics Scripps Research Institute Rockfeller University Columbia University and Informatics, Rockefeller University Paul A. MARKS, MD Bengt SAMUELSSON, MD, PhD Jan T. VILCEK, M.D. Gerald WEISSMANN, M.D. Laboratory Head of Cell Biology Nobel Laureate Professor of Microbiology Professor of Rheumatology Memorial Sloan Kettering Professor Karolinska Institutet; New York University School and Director of Biotechnology Cancer Center Former President Karolinska of Medicine Study Center Institutet; Former Chairman New York University School Nobel Foundation of Medicine 4 AWARDS COMMITTEE 2018 Susan DESMOND-HELLMANN, MD, MPh Richard AXEL, MD Michael S. BROWN, MD Laurie GLIMCHER, MD Committee Chair Nobel Laureate Nobel Laureate President and CEO Dana Farber Cancer Institute; Chief Executive Officer Co-director Professor of Molecular Genetics Professor of Medicine Bill & Melinda Gates Foundation The Kavli Institute for Brain and Internal Medicine Harvard Medical School Science. Columbia University UT Southwestern Medical Medical Centre Center at Dallas Joseph GOLDSTEIN, MD Robert S. LANGER Cato T. LAURENCIN, MD, PhD Paul A. MARKS, MD Nobel Laureate David H. Koch Institute Professor University Professor Laboratory Head of Cell Biology Professor of Molecular Genetics MIT University of Connecticut Memorial Sloan Kettering and Internal Medicine Cancer Center UT, Southwestern Medical Center at Dallas Michael ROSENBLATT, MD Bengt SAMUELSSON, MD, PhD Marc TESSIER-LAVIGNE, PhD P. Roy VAGELOS, MD Chief Medical Officer Nobel Laureate President Prix Galien USA Flagship Pioneering at Dallas Professor Stanford University Committee Chairman 2012-2017 Karolinska Institutet; Retired Chairman and CEO Former President Merck & Co., Inc.; Karolinska Institutet; Chairman of the Board Former Chairman Regeneron Pharmaceuticals, Inc. Nobel Foundation 5 Galien FORUM october 25, 2018 - 7:30AM ALEXANDRIA CENTER FOR LIFE SCIENCE NEW YORK CITY The Galien Forum, held every autumn at New York’s Alexandria Center for Life Sciences since 2010, offers a full day of dynamic presentations and spirited discussions with top scientists and industry researchers who offer perspectives on the most significant challenges in the global burden of disease and highlight the latest research and clinical pathways toward diagnosis, treatment, and cure. Topics debated at previous forums include: Our 700 attendees represent the top executive and thought > Cancer Immunotherapeutics leadership from academic research, industry, government, the regulatory community, patient organizations, international > The Brain Initiative organizations, and the media. Time and again, Forum participants > Personalized Medicine’s Impact on Drug R&D and Patient Care praise the caliber of the speakers and their fellow attendees, > Improving efficiency in Drug Development the quality of the panel discussions and presentations, and > What is “Value” and How Can it be Measured and the recognition of industry’s critical role in creating life-saving innovations. Demonstrated in Therapeutic Innovations? > U.S. Health Reform These events represent peer-to-peer exchange with a public > A New Agenda for Global Health purpose, and they feature unique opportunities to connect with > The Future of Digital Health and its Impact on Healthcare a diverse range of people, organizations, and interests, from professional and scientific groups, academia and governments to > New Mechanisms for Industry-Academia Collaboration patient associations, non-profit organizations and the media. > The Future of Targeted Drug Delivery > Microbiota in Human Disease Visit the forum webcast to read our > Autism - The Next Decade 2017 Forum Report on people and substance and to see videos and > Untangling the Web of Neurodegeneration photos from the event > Precision Medicine: Delivering on the
Load more

Recommended publications
  • Report Meeting with External Expert Participants To
    REPORT MEETING WITH EXTERNAL EXPERT PARTICIPANTS TO PROVIDE ADVICE ON A.I.D. RESEARCH PRIORITIES IN CONTRACEPTIVE DEVELOPMENT OCTOBER 20, 1982 Table of Contents page Current Program Description .................................................. 1 Input from A.I.D Mission and the Population Sector Council ................... 1 Issues and Discussion A. Current A.I.D. research modus operandi ............................... 2 B. A.I.D. technical staff ............................................... 2 C. Funding levels ....................................................... 2 D. Priorities ........................................................... 3 E. Product development .................................................. 3 F. Product planning ..................................................... 3 G. Safety studies ....................................................... 3 H. Developing country involvement ....................................... 4 I. Other points made .................................................... 5 Conclusion and Summary ....................................................... 5 Appendix Agenda ........................................................ ............ 6 Table 1 Biomedical Research for Contraceptive Development Fiscal Years 1978-1982 ........................................... 7 Table 2 Major Research Activities - IFRP ............................... 8 Table 3 Major Research Activities - PARFR, Population Council (ICCR), Johns Hopkins University ........... .......................... 9 Table 4 Principles
    [Show full text]
  • Annual Report 2018
    ANNUAL REPORT 2018 VOICES+ CHOICES ELEVATING VOICES. EXPANDING CHOICES. IMPROVING LIVES. POPULATION COUNCIL LETTER FROM THE PRESIDENT AND BOARD CHAIR 2018 was a year of rising voices, from growing demands for global action on violence against women to the UN’s dire warnings of climate catastrophe. In an increasingly noisy world, evidence is more important than ever. Rigorous research can reveal and elevate the voices and visibility of the world’s most marginalized people. That is why we are proud to lead the Population Council. For more than 65 years, our unique combination of workers. These are just a few of the ways our ideas biomedical and social science research has enabled and evidence are improving lives around the world. us to understand people’s lived realities and to develop and evaluate products and programs to In 2018, we were proud to see the latest evolution address their needs. And when we demonstrate in our more than 40 years of making the case for what does and doesn’t work, and design tailor- women and girls to be at the heart of global made solutions, people’s voices are transformed development. At a convening in Washington, D.C., into smart development investments. our researchers shared new findings from rigorous evaluations of girl-centered programs, including This year, the Population Council’s unparalleled that cash transfers more effectively improve contribution to contraceptive method choice was education, health, and economic outcomes when continued with the U.S. FDA’s approval of supported by programs that build girls’ social Annovera™. We are proud to have created the first assets and health knowledge.
    [Show full text]
  • Daily Iowan (Iowa City, Iowa), 1956-07-21
    • r.t • Miss ' Universe Contest LONG BEACH, CaUl. (It -Iowa's • Carol Morris, "Mi!s United States," this morning was named "){iss Universe" in the internation· aI beauty contest. The Queen was selected at 1 a.m. rrom a final .,oup 01 five contestants that in· , . ducted "Miss Germany," "Miss Italy," "Miss England." and "Miss e Sweden." Miss Morris is the only daughter '\eroing The State University of Iowa and the People of Iowa City " an Ottumwa. iowa, minister, and _ parents, the Rev. and Mrs. La· Established in 1868 - Five Ct'nls a Copy Member of Associated Press - AP L<>ased Wire and Photo Service Iowa City, Iowa, Saturday, July 21, t9 ~ 6 f verne Morris, were among the audio ence waitiDg ior the final session. They flew in today. ,. 'The runner·up In the contest MariDe Orschel of Germany, and "Miss Sweden" was third. Together with the title Miss Mor· H:ause Votes· Funds for riB won a six month motion picture cdntract at $250 a week. a COD vcr· Mble coupe, and numerous items ., clothing and jewelry. Tile Rev. Mr. Morris arter his dauehter's selection disclosed that ~ still carried in the toe of his Atom P·ower,Sp·ee.d-U-p lJloe a penny be found In the street ibortly before his daughter left leW8 to compete in the contest. Miss Morris is a 20-year-old Says British, Qrake University, Des Moines, w. Germany. 19wa, coed, who "wished upon a liar," ud became the 1956 "Miss . U.S." at L<!nlf Beach Municipal ' OKs Disputed Russians Are l¥IClltorium Thursda!'.
    [Show full text]
  • ED054957.Pdf
    DOCUMENT RESUME ED 054 957 SE 012 418 TITLE Mankind's Great Need, Population Research. INSTITUTION Population Crisis Committee, Washington, D.C. PUB DATE 71 NOTE 77p. EDRS PRICE MF-$0.65 HC-$3.29 DESCRIPTORS Biology; Contraception; *Demography; *Essays; Evaluation; Family Planning; Population Trends; *Research; Resource Materials; *Social Sciences ABSTRACT In an effort to assess what could and,should be done in the field of population research and theapplication of research findings, the Population Crisis Ccmmittee hascompiled this series of essays. Each is written by a recognizedauthority working in his own specialty in the field of population. The essays areshort, nontechnical statements of what could and should be donein particular areas and an estimate of a reasonable levelof funding required to produce useful results. Topics consideredrelate to basic research in reproduction, developments in contraception,social research, training and organization, and generalbackground of the need for and significance of population research.Thirty essays are presented. (BL) U.S. DEPARTMENT OF HEALTH, EDUCATIONA WELFARE OFFICE OF EDUCATION THIS DOCUMENT HAS BEEN REPRO- DUCED EXACTLY AS RECEIVED FROM THE PERSON OR ORGANIZATION ORIG- INATING IT POINTS OF VIEW OR OPIN- IONS STATED DO NOT NECESSARILY REPRESENT OFFICIAL OFFICE OF EDU- CATION POSITION OR POLICY , The 'Pop Ulation!risik:corniatteo:jkii;:ixicf9rporatreci' a.t.'0;'4.114-i4iyit'enel§:;:l'UndOtstaiitting'44n A:lareirer; eXiietiented':,V MANKIND'S GREAT NEED POPULATION RESEARCH I , I 1.' fiOPULATION CRISIS COMMITTEE 1730 K Street, N.W., Washington, D.C. 20006 ! , .,,,, CC TENTS Page Preface Andrew P_ O'Meara Introduction 1 Sheldon Segal GENERAL BACKGROUND Population Research More Urgent Than Ever 4 George B.
    [Show full text]
  • Free Executive Summary
    http://www.nap.edu/catalog/1793.html We ship printed books within 1 business day; personal PDFs are available immediately. Biomedical Politics Kathi E. Hanna, Editor; Committee to Study Decision Making, Division of Health Sciences Policy ISBN: 0-309-59757-9, 360 pages, 6 x 9, (1991) This PDF is available from the National Academies Press at: http://www.nap.edu/catalog/1793.html Visit the National Academies Press online, the authoritative source for all books from the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the National Research Council: • Download hundreds of free books in PDF • Read thousands of books online for free • Explore our innovative research tools – try the “Research Dashboard” now! • Sign up to be notified when new books are published • Purchase printed books and selected PDF files Thank you for downloading this PDF. If you have comments, questions or just want more information about the books published by the National Academies Press, you may contact our customer service department toll- free at 888-624-8373, visit us online, or send an email to [email protected]. This book plus thousands more are available at http://www.nap.edu. Copyright © National Academy of Sciences. All rights reserved. Unless otherwise indicated, all materials in this PDF File are copyrighted by the National Academy of Sciences. Distribution, posting, or copying is strictly prohibited without written permission of the National Academies Press. Request reprint permission for this book. Biomedical Politics http://www.nap.edu/catalog/1793.html i Biomedical Politics riginal paper book, not from the Kathi E.
    [Show full text]
  • Scientific Programme………………………………………………
    Welcome Note…………………………………………………….……...……….......................... 2 The Academy……………………………………………………………………………….............. 3 Secretariats and Registration Scientific Secretariat…………………………………………………………………………….................. 4 Organizing Secretariat………………………………………………………………………...................... 4 Congress Secretariat Desk.………………………………………………………………......................... 4 Registration Fees………………………………………………………………………………………….... 5 Scientific Information Format of the Congress …………………………………………………................................................ 7 Congress on-line………………………………………………………… ……………………………........ 7 Computer Projection…………………………………………………… ………………………………...... 8 Preview Room.…………………………………………………………….……………………………....... 8 Oral Presentation…………………………………………………………………………………………..... 8 Poster Session……………………………………………………………………………………………..... 8 Poster Awards……………………………………………………………………………………………...... 8 General Information Congress venue…………………………………………………………………………………………...... 9 Conference halls…………………………………………………………................................................. 9 List of Contents Secretariat………………………………………………………………………………………………........ 9 Dedicated rooms…………………………………………………………................................................. 9 Congress on-line ………………………………………………………………………………………........ 9 Exhibition area…………………………………………………………………………………………......... 9 Lunch points……………………………………………………………………………………………......... 9 Coffee……………………………………………………………………................................................... 9 Official language………………………………………………………………………………………….....
    [Show full text]
  • Norplant: the New Scarlet Letter?
    Journal of Contemporary Health Law & Policy (1985-2015) Volume 8 Issue 1 Article 15 1992 Norplant: The New Scarlet Letter? Michael T. Flannery Follow this and additional works at: https://scholarship.law.edu/jchlp Recommended Citation Michael T. Flannery, Norplant: The New Scarlet Letter?, 8 J. Contemp. Health L. & Pol'y 201 (1992). Available at: https://scholarship.law.edu/jchlp/vol8/iss1/15 This Essay is brought to you for free and open access by CUA Law Scholarship Repository. It has been accepted for inclusion in Journal of Contemporary Health Law & Policy (1985-2015) by an authorized editor of CUA Law Scholarship Repository. For more information, please contact [email protected]. NORPLANT: THE NEW SCARLET LETTER? Michael T. Flannery* [W]hat is it but to laugh in the faces of our godly magistrates, and make a pride out of what they, worthy gentlemen, meant for a punishment?1 Hester Prynne lived in the eighteenth century in an early New England, Puritan colony and is a character of Nathaniel Hawthorne's classic Ameri- can novel, The Scarlet Letter.2 Darlene Johnson was born in 1964 and pres- ently lives in California.' Except for the decision of Judge Howard Broadman,4 these two women would have nothing in common. However, when Judge Broadman ordered Darlene Johnson to undergo the implanta- tion of Norplant5 to effectuate sterilization,6 the two women then shared a common bond: for the crime they each committed, both were sentenced, in effect, to shame. Hester's crime was adultery; Darlene's crime was child abuse." What is ironic is that in an age when criminals were chained to the * Assistant City Solicitor, Law Department, City of Philadelphia; B.A., The University of Delaware; J.D., The Catholic University of America, The Columbus School of Law.
    [Show full text]
  • Annual Report 2018
    ANNUAL REPORT 2018 VOICES+ CHOICES ELEVATING VOICES. EXPANDING CHOICES. IMPROVING LIVES. POPULATION COUNCIL LETTER FROM THE PRESIDENT AND BOARD CHAIR 2018 was a year of rising voices, from growing demands for global action on violence against women to the UN’s dire warnings of climate catastrophe. In an increasingly noisy world, evidence is more important than ever. Rigorous research can reveal and elevate the voices and visibility of the world’s most marginalized people. That is why we are proud to lead the Population Council. For more than 65 years, our unique combination of workers. These are just a few of the ways our ideas biomedical and social science research has enabled and evidence are improving lives around the world. us to understand people’s lived realities and to develop and evaluate products and programs to In 2018, we were proud to see the latest evolution address their needs. And when we demonstrate in our more than 40 years of making the case for what does and doesn’t work, and design tailor- women and girls to be at the heart of global made solutions, people’s voices are transformed development. At a convening in Washington, D.C., into smart development investments. our researchers shared new findings from rigorous evaluations of girl-centered programs, including This year, the Population Council’s unparalleled that cash transfers more effectively improve contribution to contraceptive method choice was education, health, and economic outcomes when continued with the U.S. FDA’s approval of supported by programs that build girls’ social Annovera™. We are proud to have created the first assets and health knowledge.
    [Show full text]
  • Sg Galien 2009-8P.Qxt
    preliminary SPONSORSHIP 2009guide Prix Galien USA Committee Michael S. Brown, M.D. Nobel Laureate Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas Walter Gilbert, Ph.D. Nobel Laureate Carl M. Loeb University Professor Emeritus, Harvard University Joseph Goldstein, M.D. Nobel Laureate Worldwide, the Prix Galien is regarded Professor of Molecular Genetics and Internal Medicine, as the equivalent of the Nobel Prize UT, Southwestern Medical Center at Dallas in biopharmaceutical research. Paul Greengard, Ph.D. Nobel Laureate Vincent Astor Professor of Molecular and Cellular The award recognizes outstanding Neuroscience, Rockefeller University achievements in improving the global Eric R. Kandel, M.D. human condition through the Nobel Laureate Professor of Physiology and Cellular Biophysics, development of innovative therapies. Columbia University Richard A. Lerner, M.D. The Prix Galien was created in 1970 Lita Annenberg Hazen Professor of Immunochemistry, Chair in Chemistry, Scripps Research Institute in honor of Galen, the father of medical science and modern Paul A. Marks. M.D. pharmacology. Laboratory Head of Cell Biology, Memorial Sloan Kettering Cancer Center Bengt Samuelsson M.D. Ph.D. Nobel Laureate Professor, Karolinska Institute, Former President of Karolinska Institutet and Chairman of the Nobel Foundation Jan T.Vilcek, M.D. Professor of Microbiology, New York University School of Medicine The Prix Galien Medal Gerald Weissmann, M.D. Research Professor of Medicine (Rheumatology) Albert de Jaeger (1908 – 1992), who was awarded and Director of the Biotechnology Study Center, the Premier Grand Prix de Rome architectural prize, NYU School of Medicine designed the Prix Galien medal. He designed the Weizsman Institute medal, and medals for prominent figures such as Pope Pius XII (in 1937 at the Villa Medicis) and Pope Jean-Paul I, Elie Wiesel Presidents Dwight D.
    [Show full text]
  • Pro Bonofinal.LD
    CONTACT: Brandi Horton (202) 248-5447 FOR IMMEDIATE RELEASE Population Council, Sheldon Segal to Be Celebrated by Prix Galien USA Pro Bono Humanum Award recognizes exemplary partnership benefiting reproductive health of more than 8 million women NEW YORK (July 17, 2008) — The Population Council and Sheldon Segal, distinguished scientist at the organization, will receive the Prix Galien USA 2008 Pro Bono Humanum Award (http://www.prix-galien- usa.com) for spearheading a preeminent coalition between academic, private, philanthropic and industrial organizations that made possible the development and distribution of implantable hormone delivery systems, such as Norplant®, that are used by more than 8 million women worldwide. The award also will recognize other coalition members the Rockefeller Brothers Fund, the late Judah Folkman of Harvard University, Dow-Corning and Wyeth. The award will be presented September 24, 2008, at the American Museum of Natural History in New York City. The Pro Bono Humanum Award will honor the Population Council and Segal for five decades of a science-based global effort in support of reproductive health and family planning, especially in underdeveloped or underserved populations. This initiative was critical in establishing a coalition to create Norplant® (levonorgestrel implants) and related hormone delivery systems, which came as the result of basic biomedical discovery and translational research and was put into practice thanks to the waiving of proprietary patent rights for the Population Council. “The significance of Norplant® is more than convenient birth control,” said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.
    [Show full text]
  • Contraceptive Update
    CONTRACEPTIVE UPDATE DR. SHELDON SEGAL* I. INTRODUCTION Worldwide, there has been a dramatic increase in contraceptive use over the past thirty-five years. The number of couples using systems of fertility control (the prevalence rate) has increased more than tenfold. In developing countries, the number of contraceptive users increased from under 30 million before 1960, to almost 400 million in 1996. The percent of couples in the reproductive age group using contraception has increased from 8 percent to over 50 percent and is continuing to rise in most of the developing world.' Consequently, fertility has been steadily declining. In developing countries, the number of children a woman will have in her lifetime has decreased from approximately six in the 1960s, to less than four today2 Most industrialized countries are at, or even below, replacement levels of fertility. National surveys have provided detailed information on the methods that people choose to prevent pregnancy. Around the world, contraception is practiced chiefly by women. Surgical sterilization, primarily tubal liga- tion, ranks first among methods chosen by American couples. 3 Oral con- traception is the most widely used reversible method.4 In other countries, the pattern is different. In Sweden and France, the intrauterine device (IUD)is the preferred reversible method.' In Japan, modem hormonal methods for women are not openly available, and the predominant method of birth control is the condom.6 Given the high failure rate of condom use, this means that many women ultimately must resort to having an abortion. Over one quarter of pregnancies in Japan are voluntarily terminated.7 * Distinguished Scientist at the Population Council, New York, NY.
    [Show full text]
  • Support (Earth) Hood
    THE NUOAZINI Or SUBSTANCE VOL. XIX SUMMER 1991 $2.95 FOR PROGRESSIVE WOMEN SUPPORT OF (EARTH) HOOD A Conversation with Earth First! Activist Judi Bari • The Uncommon Women of Greenham • Critiques W'a of New Contraceptives • • — m WmBK -It I •in I =00 =^ I =b I -•* --* New Books for Women on Women's Concerns! JEWISH WOMEN IN WOMEN AND DIVORCE/ THERAPY MEN AND DIVORCE Seen But Not Heard Gender Differences in Edited by Rachel Josefowitz Siegel, MSW, Separation, Divorce, and Ellen Cole, PhD and Remarriage "The [chapters] in this volume are marked by WOMAN-DEFINED compassion, intimacy, and a feminist willing- Edited by Sandra S. Volgy, PhD MOTHERHOOD ness to explore the terrain where the personal, "Solid research based data for gender issues in the mythical, the historical, the pathological, separation, divorce, and remarriage.... It is a Edited by Jane Price Knowles, MD, and the therapeutic all intersect."—Susan very valuable resource for the clinician who takes and Ellen Cole, PhD Weidman Schneider, Editor, Lilith Magazine; seriously the need for substantive date analysis "An intellectually and emotionally riveting Author of Jewish and Female and results. It is also a book which could be very book. The contributions from these talented au- Here is the first volume ever to focus on the helpful to an individual or couple who want to thors expose the unidimensional myths of issues of Jewish women in the context of coun- have more cognitive data and a deeper under- motherhood and delineate the multifaceted na- seling and psychotherapy. The authors convey standing of both men and women and divorce is- ture of being a mother...
    [Show full text]